Risk Paradigm Group’s Pfizer PFE Stock Holding History

Risk Paradigm Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-2,752	Closed	-$92.7K	–	179
2018 Q1	$92.7K	Sell	2,752 -201	-7%	-$6.91K	0.12%	118
2017 Q4	$101K	Hold	2,953	–	–	0.11%	126
2017 Q3	$100K	Sell	2,953 -25,680	-90%	-$825K	0.12%	112
2017 Q2	$913K	Buy	28,633 +25,673	+867%	+$810K	1.07%	28
2017 Q1	$96.1K	Sell	2,960 -1,785	-38%	-$56.3K	0.11%	107
2016 Q4	$146K	Hold	4,745	–	–	0.16%	104
2016 Q3	$152K	Buy	4,745 +211	+5%	+$7.05K	0.11%	112
2016 Q2	$151K	Hold	4,534	–	–	0.21%	93
2016 Q1	$128K	Sell	4,534 -1,678	-27%	-$47.9K	0.16%	83
2015 Q4	$190K	Buy	6,212 +1,187	+24%	+$37.3K	0.22%	62
2015 Q3	$150K	Buy	5,025 +1,957	+64%	+$62.7K	0.31%	49
2015 Q2	$97.6K	Buy	3,068 +105	+4%	+$3.42K	0.09%	91
2015 Q1	$97.8K	Buy	+2,963	New	+$94.2K	0.1%	89

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Risk Paradigm Group's PFE Position: Q2 2018 in Review

Risk Paradigm Group sold out of Pfizer (PFE) in Q2 2018, closing a stake of 2,752 shares — an estimated $92.7K sold.

Risk Paradigm Group first reported a position in PFE in Q1 2015 and held it in 13 quarters. The position peaked at $913K in Q2 2017. 2,204 funds tracked by Wall St. Rank hold PFE as of Q2 2018.

Risk Paradigm Group reported no remaining Pfizer position as of Q2 2018 after selling out during the quarter.
Risk Paradigm Group sold 2,752 Pfizer shares in Q2 2018, an estimated $92.7K.
Risk Paradigm Group first reported a position in Pfizer in Q1 2015 and held it in 13 quarters.
Risk Paradigm Group's Pfizer position peaked at $913K in Q2 2017.
2,204 funds tracked by Wall St. Rank held Pfizer as of Q2 2018.

Based on Risk Paradigm Group's 13F filing for Q2 2018, filed 10 Aug 2018.